Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients-Reference-Cited by-同舟云学术

Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients

Published:2017-11 Issue:11 Volume:101 Page:2780-2788
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Arns Wolfgang,Huppertz Andrea,Rath Thomas,Ziefle Stephan,Rump Lars C.,Hansen Anita,Budde Klemens,Lehner Lukas J.,Shipkova Maria,Baeumer Daniel,Kroeger Irena,Sieder Christian,Klein Thomas,Schenker Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients.;Kidney;Am J Transplant,2009

2. European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugs;Van Gelder;Transpl Int,2011

3. Pharmacokinetics of tacrolimus-based combination therapies;Undre;Nephrol Dial Transplant,2003

4. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence evaluation and blood concentration estimation of generic and branded tacrolimus in healthy subjects under fasting: A randomized, four-periods, two-sequences, complete repeated, crossover study;Transplant Immunology;2023-12

2. Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding;Pharmaceutics;2023-08-29

3. Comparative Safety and Efficacy of Immunosuppressive Regimens Post-Kidney Transplant: A Systematic Review;Cureus;2023-08-22

4. Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: A systematic review and meta-analysis;Journal of the American Pharmacists Association;2023-05

5. Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation;Transplant International;2022-05-20